Market Overview:
The global plasma protein products market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising demand for plasma protein products for the treatment of various disorders, and technological advancements in the field of plasma protein products. Based on type, the global plasma protein products market is segmented into albumin, immunoglobulin, coagulation factor and others. Albumin held a major share of the global market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to its high demand for treating various medical conditions such as burns, shock and dehydration. Immunoglobulin is also anticipated to witness significant growth during the forecast period owing to its increasing use in therapies for primary immunodeficiency disorder (PIDD) and hereditary angioedema (HAE). Based on application,the global plasma protein products market is segmented into hemophilia A & B therapy, primary immunodeficiency disorder therapy (PIDD), hereditary angioedema therapy (HAE) and others.
Product Definition:
Plasma protein products are used to treat medical conditions that are caused by a lack or deficiency of certain proteins in the blood. These products can be used to replace missing proteins, or to help the body make its own proteins.
Albumin:
Albumin is a protein that is found in the human blood and urine. It helps maintain the fluid balance, acts as an anti-coagulant and has been used as a plasma expander for several medical applications such as treatment of hypoalbuminemia. The global albumin market is expected to grow at a significant rate owing to increasing demand for its usage in various end-use industries such as pharmaceuticals, food & beverages and cosmetics among others.
Immunoglobulin:
immunoglobulin is a protein-based medication used to treat chronic immune disorders. Immunoglobulins are also utilized in the treatment of acute inflammatory conditions and some neurological diseases. The most common types of immunoglobulin include IgA, IgD, and IgE which differ in terms of their molecular size & binding properties.
Global Immunoglobulin.
Application Insights:
On the basis of application, the global market has been segmented into hemophilia, primary immunodeficiency disorders (PID), hereditary angioedema, and others. Primary immunodeficiency disorders are caused due to a defect in the immune system which results in reduced ability to fight infections and diseases. The incidence of primary immunodeficiency disorders is increasing with age owing to factors such as unhealthy lifestyle including smoking and alcohol consumption. According to WHO estimation, around 35 million people were affected by this disease globally in 2017 which was a rise of around 10% from 2016.
Hereditary angioedema is another major segment where PP products are used for treatment purposes owing to high success rate associated with its use coupled with low risk of any side effects compared to other drugs employed for same purpose.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturers coupled with high R&D expenditure and technological advancements are some factors responsible for its continued dominance over the forecast period. Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing healthcare spending, rising awareness about plasma protein therapeutics, and growing need for blood plasma-derived products due to population growth and urbanization in this region. Moreover, government initiatives such as “Make in India†campaign by Indian government are expected to create ample opportunities for industry players operating within this region thereby driving regional growth over the next eight years.
Growth Factors:
- Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. Chronic diseases are characterized by long-term symptoms and require ongoing treatment. As a result, there is a growing demand for plasma protein products that can help in the treatment of these conditions.
- Technological advancements: The plasma protein products market is witnessing rapid technological advancements, which are helping to improve the quality and efficacy of these products. This is resulting in an increase in their demand from both healthcare professionals and consumers alike.
- Growing awareness about benefits: There has been a growing awareness about the benefits offered by plasma protein products among consumers worldwide, which is helping to drive their demand significantly. These benefits include improved wound healing, reduced inflammation, better blood circulation, etc., which are making them increasingly popular among people looking for effective ways to improve their health condition..
Scope Of The Report
Report Attributes
Report Details
Report Title
Plasma Protein Products Market Research Report
By Type
Albumin, Immunoglobulin, Coagulation Factor, Others
By Application
Hemophilia, Primary Immunodeficiency Disorder, Hereditary Angioedema, Others
By Companies
CSL Plasma, Grifols, Biotest, Kedrion, Kamada, Octapharma, China Biologic Products Holdings, Hualan Biological Engineering
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Plasma Protein Products Market Report Segments:
The global Plasma Protein Products market is segmented on the basis of:
Types
Albumin, Immunoglobulin, Coagulation Factor, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hemophilia, Primary Immunodeficiency Disorder, Hereditary Angioedema, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CSL Plasma
- Grifols
- Biotest
- Kedrion
- Kamada
- Octapharma
- China Biologic Products Holdings
- Hualan Biological Engineering
Highlights of The Plasma Protein Products Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Albumin
- Immunoglobulin
- Coagulation Factor
- Others
- By Application:
- Hemophilia
- Primary Immunodeficiency Disorder
- Hereditary Angioedema
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Plasma Protein Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Plasma protein products are proteins that have been isolated from human blood plasma. Plasma proteins are important because they can help the body to fight infections and other diseases.
Some of the major players in the plasma protein products market are CSL Plasma, Grifols, Biotest, Kedrion, Kamada, Octapharma, China Biologic Products Holdings, Hualan Biological Engineering.
The plasma protein products market is expected to grow at a compound annual growth rate of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Plasma Protein Products Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Plasma Protein Products Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Plasma Protein Products Market - Supply Chain
4.5. Global Plasma Protein Products Market Forecast
4.5.1. Plasma Protein Products Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Plasma Protein Products Market Size (000 Units) and Y-o-Y Growth
4.5.3. Plasma Protein Products Market Absolute $ Opportunity
5. Global Plasma Protein Products Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Plasma Protein Products Market Size and Volume Forecast by Type
5.3.1. Albumin
5.3.2. Immunoglobulin
5.3.3. Coagulation Factor
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Plasma Protein Products Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Plasma Protein Products Market Size and Volume Forecast by Application
6.3.1. Hemophilia
6.3.2. Primary Immunodeficiency Disorder
6.3.3. Hereditary Angioedema
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Plasma Protein Products Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Plasma Protein Products Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Plasma Protein Products Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Plasma Protein Products Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Plasma Protein Products Demand Share Forecast, 2019-2026
9. North America Plasma Protein Products Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Plasma Protein Products Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Plasma Protein Products Market Size and Volume Forecast by Application
9.4.1. Hemophilia
9.4.2. Primary Immunodeficiency Disorder
9.4.3. Hereditary Angioedema
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Plasma Protein Products Market Size and Volume Forecast by Type
9.7.1. Albumin
9.7.2. Immunoglobulin
9.7.3. Coagulation Factor
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Plasma Protein Products Demand Share Forecast, 2019-2026
10. Latin America Plasma Protein Products Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Plasma Protein Products Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Plasma Protein Products Market Size and Volume Forecast by Application
10.4.1. Hemophilia
10.4.2. Primary Immunodeficiency Disorder
10.4.3. Hereditary Angioedema
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Plasma Protein Products Market Size and Volume Forecast by Type
10.7.1. Albumin
10.7.2. Immunoglobulin
10.7.3. Coagulation Factor
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Plasma Protein Products Demand Share Forecast, 2019-2026
11. Europe Plasma Protein Products Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Plasma Protein Products Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Plasma Protein Products Market Size and Volume Forecast by Application
11.4.1. Hemophilia
11.4.2. Primary Immunodeficiency Disorder
11.4.3. Hereditary Angioedema
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Plasma Protein Products Market Size and Volume Forecast by Type
11.7.1. Albumin
11.7.2. Immunoglobulin
11.7.3. Coagulation Factor
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Plasma Protein Products Demand Share, 2019-2026
12. Asia Pacific Plasma Protein Products Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Plasma Protein Products Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Plasma Protein Products Market Size and Volume Forecast by Application
12.4.1. Hemophilia
12.4.2. Primary Immunodeficiency Disorder
12.4.3. Hereditary Angioedema
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Plasma Protein Products Market Size and Volume Forecast by Type
12.7.1. Albumin
12.7.2. Immunoglobulin
12.7.3. Coagulation Factor
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Plasma Protein Products Demand Share, 2019-2026
13. Middle East & Africa Plasma Protein Products Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Plasma Protein Products Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Plasma Protein Products Market Size and Volume Forecast by Application
13.4.1. Hemophilia
13.4.2. Primary Immunodeficiency Disorder
13.4.3. Hereditary Angioedema
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Plasma Protein Products Market Size and Volume Forecast by Type
13.7.1. Albumin
13.7.2. Immunoglobulin
13.7.3. Coagulation Factor
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Plasma Protein Products Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Plasma Protein Products Market: Market Share Analysis
14.2. Plasma Protein Products Distributors and Customers
14.3. Plasma Protein Products Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. CSL Plasma
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Grifols
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Biotest
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Kedrion
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Kamada
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Octapharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. China Biologic Products Holdings
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Hualan Biological Engineering
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
